nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—EBP—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.0189	0.0199	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0157	0.0165	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0157	0.0165	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0137	0.0144	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0137	0.0144	CbGpPWpGaD
Pentazocine—EBP—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.0129	0.0135	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0129	0.0135	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0123	0.0129	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0123	0.0129	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0118	0.0125	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0116	0.0122	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0116	0.0122	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—PENK—narcolepsy	0.0115	0.0121	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0113	0.0119	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0107	0.0113	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0107	0.0113	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0105	0.011	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0105	0.011	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0104	0.0109	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0101	0.0107	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—PENK—narcolepsy	0.01	0.0106	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00974	0.0102	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—PENK—narcolepsy	0.00966	0.0102	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.00953	0.01	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00921	0.00969	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00921	0.00969	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00908	0.00955	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00908	0.00955	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00889	0.00935	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00877	0.00923	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00862	0.00907	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00854	0.00899	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—PENK—narcolepsy	0.00849	0.00893	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—PENK—narcolepsy	0.00847	0.00892	CbGpPWpGaD
Pentazocine—EBP—Metabolism—CHKB—narcolepsy	0.00843	0.00887	CbGpPWpGaD
Pentazocine—OPRD1—forebrain—narcolepsy	0.00839	0.169	CbGeAlD
Pentazocine—OPRK1—forebrain—narcolepsy	0.00804	0.162	CbGeAlD
Pentazocine—OPRD1—GPCR ligand binding—HCRTR2—narcolepsy	0.00799	0.00841	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—HCRTR1—narcolepsy	0.00799	0.00841	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00778	0.00819	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00778	0.00819	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—P2RY11—narcolepsy	0.00772	0.00812	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00768	0.00809	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00756	0.00795	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00751	0.00791	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00722	0.0076	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—HRH3—narcolepsy	0.00721	0.00758	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—PENK—narcolepsy	0.00716	0.00754	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00708	0.00745	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00708	0.00745	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—HCRTR1—narcolepsy	0.00701	0.00738	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—HCRTR2—narcolepsy	0.00701	0.00738	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—P2RY11—narcolepsy	0.00677	0.00712	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00674	0.00709	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00669	0.00704	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—HCRT—narcolepsy	0.00657	0.00691	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00653	0.00687	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00639	0.00672	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—HRH3—narcolepsy	0.00632	0.00665	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00621	0.00653	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00621	0.00653	CbGpPWpGaD
Pentazocine—OPRM1—brainstem—narcolepsy	0.00593	0.12	CbGeAlD
Pentazocine—OPRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00592	0.00623	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00592	0.00623	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00586	0.00617	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—PENK—narcolepsy	0.00585	0.00616	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—HCRT—narcolepsy	0.00576	0.00606	CbGpPWpGaD
Pentazocine—EBP—Metabolism—CPT1B—narcolepsy	0.00573	0.00603	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00573	0.00603	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00573	0.00603	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00572	0.00602	CbGpPWpGaD
Pentazocine—OPRM1—forebrain—narcolepsy	0.00572	0.115	CbGeAlD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00569	0.00599	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—HRH3—narcolepsy	0.00534	0.00562	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00525	0.00552	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00525	0.00552	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—PENK—narcolepsy	0.00513	0.0054	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00502	0.00529	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—TRH—narcolepsy	0.00498	0.00524	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00496	0.00521	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—HCRT—narcolepsy	0.00487	0.00512	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00484	0.00509	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00475	0.00499	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00475	0.00499	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00452	0.00475	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00452	0.00475	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—P2RY11—narcolepsy	0.00436	0.00459	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—TRH—narcolepsy	0.00436	0.00459	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—HRH3—narcolepsy	0.00436	0.00459	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—PENK—narcolepsy	0.00434	0.00456	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00425	0.00447	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00416	0.00438	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00416	0.00438	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HCRTR1—narcolepsy	0.0041	0.00432	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HCRTR2—narcolepsy	0.0041	0.00432	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—P2RY11—narcolepsy	0.00396	0.00417	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00396	0.00417	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00396	0.00417	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—P2RY11—narcolepsy	0.00383	0.00403	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—HRH3—narcolepsy	0.00383	0.00403	CbGpPWpGaD
Pentazocine—OPRM1—midbrain—narcolepsy	0.00378	0.0762	CbGeAlD
Pentazocine—OPRD1—GPCR downstream signaling—HCRT—narcolepsy	0.00371	0.0039	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—TRH—narcolepsy	0.00369	0.00388	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—TAC1—narcolepsy	0.00362	0.0038	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—NPS—narcolepsy	0.00362	0.0038	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HCRTR1—narcolepsy	0.0036	0.00379	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HCRTR2—narcolepsy	0.0036	0.00379	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00352	0.0037	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00352	0.0037	CbGpPWpGaD
Pentazocine—OPRD1—brain—narcolepsy	0.00348	0.0702	CbGeAlD
Pentazocine—OPRK1—Signaling by GPCR—P2RY11—narcolepsy	0.00347	0.00366	CbGpPWpGaD
Pentazocine—SIGMAR1—medulla oblongata—narcolepsy	0.00341	0.0689	CbGeAlD
Pentazocine—OPRD1—Signaling by GPCR—HCRT—narcolepsy	0.00337	0.00354	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00335	0.00352	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00335	0.00352	CbGpPWpGaD
Pentazocine—OPRK1—brain—narcolepsy	0.00334	0.0673	CbGeAlD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00333	0.00351	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PENK—narcolepsy	0.00331	0.00348	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—HCRT—narcolepsy	0.00325	0.00342	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00323	0.0034	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—HRH3—narcolepsy	0.00323	0.0034	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—NPS—narcolepsy	0.00317	0.00334	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—TAC1—narcolepsy	0.00317	0.00334	CbGpPWpGaD
Pentazocine—SIGMAR1—midbrain—narcolepsy	0.00312	0.063	CbGeAlD
Pentazocine—OPRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00304	0.0032	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00304	0.0032	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PENK—narcolepsy	0.003	0.00316	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HCRT—narcolepsy	0.00295	0.00311	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00294	0.00309	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00292	0.00308	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PENK—narcolepsy	0.0029	0.00305	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00286	0.003	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—TRH—narcolepsy	0.00281	0.00296	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00275	0.00289	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—TAC1—narcolepsy	0.00268	0.00282	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—NPS—narcolepsy	0.00268	0.00282	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PENK—narcolepsy	0.00263	0.00277	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—TRH—narcolepsy	0.00255	0.00269	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0025	0.00263	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HCRT—narcolepsy	0.0025	0.00263	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00247	0.0026	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—HRH3—narcolepsy	0.00247	0.00259	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—TRH—narcolepsy	0.00247	0.00259	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PENK—narcolepsy	0.00245	0.00258	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HCRTR1—narcolepsy	0.00242	0.00255	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HCRTR2—narcolepsy	0.00242	0.00255	CbGpPWpGaD
Pentazocine—OPRM1—brain—narcolepsy	0.00237	0.0479	CbGeAlD
Pentazocine—OPRD1—Signaling Pathways—P2RY11—narcolepsy	0.00234	0.00246	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—TRH—narcolepsy	0.00224	0.00236	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HRH3—narcolepsy	0.00224	0.00236	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PENK—narcolepsy	0.00223	0.00234	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—HTR2A—narcolepsy	0.00217	0.00229	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—HRH3—narcolepsy	0.00216	0.00227	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HCRTR2—narcolepsy	0.00213	0.00224	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HCRTR1—narcolepsy	0.00213	0.00224	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00212	0.00223	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—TRH—narcolepsy	0.00208	0.00219	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—P2RY11—narcolepsy	0.00205	0.00216	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—NPS—narcolepsy	0.00204	0.00215	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—TAC1—narcolepsy	0.00204	0.00215	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HCRT—narcolepsy	0.00199	0.00209	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HRH3—narcolepsy	0.00196	0.00207	CbGpPWpGaD
Pentazocine—SIGMAR1—brain—narcolepsy	0.00196	0.0396	CbGeAlD
Pentazocine—OPRK1—GPCR ligand binding—HTR2A—narcolepsy	0.00191	0.00201	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—TRH—narcolepsy	0.00189	0.00199	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—TAC1—narcolepsy	0.00186	0.00195	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—NPS—narcolepsy	0.00186	0.00195	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HRH3—narcolepsy	0.00183	0.00192	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HCRTR1—narcolepsy	0.0018	0.00189	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HCRTR2—narcolepsy	0.0018	0.00189	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—NPS—narcolepsy	0.00179	0.00188	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—TAC1—narcolepsy	0.00179	0.00188	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PENK—narcolepsy	0.00177	0.00187	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HCRT—narcolepsy	0.00175	0.00184	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—P2RY11—narcolepsy	0.00173	0.00183	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HRH3—narcolepsy	0.00166	0.00175	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—NPS—narcolepsy	0.00163	0.00171	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—TAC1—narcolepsy	0.00163	0.00171	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—HTR2A—narcolepsy	0.00161	0.0017	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PENK—narcolepsy	0.00156	0.00164	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—TAC1—narcolepsy	0.00151	0.00159	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—NPS—narcolepsy	0.00151	0.00159	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TRH—narcolepsy	0.00151	0.00159	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HCRT—narcolepsy	0.00148	0.00155	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—NPS—narcolepsy	0.00137	0.00145	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—TAC1—narcolepsy	0.00137	0.00145	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TRH—narcolepsy	0.00132	0.00139	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HRH3—narcolepsy	0.00132	0.00139	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PENK—narcolepsy	0.00131	0.00138	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—HTR2A—narcolepsy	0.00123	0.00129	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HRH3—narcolepsy	0.00116	0.00122	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TRH—narcolepsy	0.00112	0.00118	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HTR2A—narcolepsy	0.00112	0.00117	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NPS—narcolepsy	0.0011	0.00115	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TAC1—narcolepsy	0.0011	0.00115	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—HTR2A—narcolepsy	0.00108	0.00113	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HRH3—narcolepsy	0.00098	0.00103	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HTR2A—narcolepsy	0.000979	0.00103	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NPS—narcolepsy	0.000961	0.00101	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TAC1—narcolepsy	0.000961	0.00101	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000911	0.000958	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000827	0.00087	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TAC1—narcolepsy	0.000812	0.000855	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NPS—narcolepsy	0.000812	0.000855	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR2A—narcolepsy	0.000659	0.000694	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR2A—narcolepsy	0.000578	0.000608	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR2A—narcolepsy	0.000489	0.000514	CbGpPWpGaD
